David Hochman
Chief Executive Officer at ORCHESTRA BIOMED HOLDINGS, INC.
Net worth: 4 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Darren Sherman | M | 52 |
Caliber Therapeutics, Inc.
 Caliber Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Caliber Therapeutics, Inc. is a holding company, which engages in the development of products for atherosclerotic diseases. It offers targeted angioplasty drug delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices. The company was founded on August 3, 2009 and is headquartered in New Hope, PA.
Orchestra BioMed, Inc.
 Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA.
FreeHold Surgical LLC
 FreeHold Surgical LLC Medical SpecialtiesHealth Technology Part of Orchestra Biomed Holdings, Inc., FreeHold Surgical LLC is a company that specializes in surgical retractors. The company is based in New Hope, PA. The company's retractors are the only fully and continuously adjustable, completely intracorporeal retractors designed for hands-free tissue retraction. The company was founded by David P. Hochman.
BackBeat Medical LLC
 BackBeat Medical LLC Electronic Equipment/InstrumentsElectronic Technology BackBeat Medical, Inc. develops implantable cardiac stimulation devices. It offers devices for the treatment of hypertension. The firm provides apparatus to increase secretion of endogenous natriuretic hormones. The company was founded by Robert A. van Tassel in January 2011 and is headquartered in New Hope, PA.
Motus G.I. Medical Technologies Ltd.
 Motus G.I. Medical Technologies Ltd. Medical SpecialtiesHealth Technology Motus G.I. Medical Technologies Ltd. develops a system for diagnosis and treatment of large intestine diseases. The company was founded by Boris Shtul on October 6, 2008 and is headquartered in Tirat Carmel, Israel. | 15 years |
| Mark Pomeranz | M | 63 |
Motus G.I. Medical Technologies Ltd.
Motus G.I. Medical Technologies Ltd. Medical SpecialtiesHealth Technology Motus G.I. Medical Technologies Ltd. develops a system for diagnosis and treatment of large intestine diseases. The company was founded by Boris Shtul on October 6, 2008 and is headquartered in Tirat Carmel, Israel. | 10 years |
| Timothy Moran | M | 52 | 6 years | |
| Alan Holmer | M | 74 |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 years |
| Peter Salzmann | M | 56 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 4 years |
| Ravit Ram | M | 50 | 6 years | |
| Avery Catlin | M | 75 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 years |
| Sean Moran | M | 66 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 years |
| Jacques Suzanne | F | 53 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 5 years |
| John Jenkins | M | 66 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 6 years |
| Robert Discordia | M | 60 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 6 years |
| Justin Davis-Rice | M | 53 | 7 years | |
| Eric Rose | M | 73 |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | 6 years |
| Pamela Connealy | F | 63 |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | 4 years |
| Yuval Cohen | M | 49 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 11 years |
| Andrew Taylor | M | 53 | 7 years | |
| Yuval Mika | M | 66 |
BackBeat Medical LLC
BackBeat Medical LLC Electronic Equipment/InstrumentsElectronic Technology BackBeat Medical, Inc. develops implantable cardiac stimulation devices. It offers devices for the treatment of hypertension. The firm provides apparatus to increase secretion of endogenous natriuretic hormones. The company was founded by Robert A. van Tassel in January 2011 and is headquartered in New Hope, PA. | 13 years |
| George Golumbeski | M | 67 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 1 years |
| Sonja Nelson | F | 51 | 3 years | |
| Eric Fain | M | 63 |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | 6 years |
| Tim McInerney | M | 63 |
Adgero Biopharmaceuticals Holdings, Inc.
 Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | 8 years |
| Jason Aryeh | M | 56 |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | 6 years |
| Geoffrey Smith | M | - |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | 6 years |
| Gary Pruden | M | 62 | 7 years | |
| Barbara White | M | 73 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 11 years |
| Scott Durbin | M | 55 | 1 years | |
| Dennis J. Donohoe | M | 72 | - | |
| Andrea Fischer Newman | F | 65 |
University of Michigan
| 29 years |
| Steven W. Pipe | M | - |
University of Michigan
| 31 years |
| Ziv Belsky | M | 55 | - | |
| Lennard A. Fisk | M | 80 |
University of Michigan
| 31 years |
| Noreen Gordon Sablotsky | F | - |
Motus G.I. Medical Technologies Ltd.
Motus G.I. Medical Technologies Ltd. Medical SpecialtiesHealth Technology Motus G.I. Medical Technologies Ltd. develops a system for diagnosis and treatment of large intestine diseases. The company was founded by Boris Shtul on October 6, 2008 and is headquartered in Tirat Carmel, Israel. | - |
| Gibran Ahmed | M | - | 2 years | |
| Steve Hochberg | M | 62 |
Motus G.I. Medical Technologies Ltd.
Motus G.I. Medical Technologies Ltd. Medical SpecialtiesHealth Technology Motus G.I. Medical Technologies Ltd. develops a system for diagnosis and treatment of large intestine diseases. The company was founded by Boris Shtul on October 6, 2008 and is headquartered in Tirat Carmel, Israel. | - |
| Lucas Joynt | M | - |
Citizens Committee for New York City
| 8 years |
| Arnel Aquino | M | - |
Augment Securities, Inc.
 Augment Securities, Inc. Investment ManagersFinance Augment Securities, Inc. (Augment Securities) is a venture capital firm, a subsidiary of Spencer Trask & Co. founded in 1991 by Kevin Brian Kimberlin. The firm is headquartered in New York. | 24 years |
| Robert Laughner | M | 43 | 4 years | |
| Hans-Peter Stoll | M | 68 | 2 years | |
| J. C. Simeon | M | - | 1 years | |
| Kunal Faldu | M | - | - | |
| Elad Amor | M | 41 | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alex McAulay | M | 40 | 3 years | |
| Gary Jacobs | M | 67 |
Motus G.I. Medical Technologies Ltd.
Motus G.I. Medical Technologies Ltd. Medical SpecialtiesHealth Technology Motus G.I. Medical Technologies Ltd. develops a system for diagnosis and treatment of large intestine diseases. The company was founded by Boris Shtul on October 6, 2008 and is headquartered in Tirat Carmel, Israel. | 4 years |
| John Eric Krakowiak | M | - |
University of Michigan
| 5 years |
| Avi Rubin | M | - |
University of Michigan
| 9 years |
| Frank G. Pilkiewicz | M | 77 |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | - |
| Mark A. Tepper | M | 49 | 10 years | |
| Stein John | M | - |
University of Michigan
| 12 years |
| Brian Scott Stutland | M | 49 |
University of Michigan
| 6 years |
| Michael Flanagan | M | 72 | 2 years | |
| Simeon Denchev Djankov | M | 54 |
University of Michigan
| - |
| Michelle Epstein Taigman | F | 55 |
University of Michigan
| 7 years |
| Lori Wheeler-Naess | F | 53 |
University of Michigan
| 5 years |
| Paul Hayes | M | 58 | 3 years | |
| Zoltan Gombosi | M | - |
University of Michigan
| 6 years |
| Chi Ho Wong | M | 45 |
University of Michigan
| 5 years |
| Jesse Warner Cole | M | 51 | 3 years | |
| Richard Anthony Consul | M | - |
University of Michigan
| 11 years |
| Shai Novik | M | 58 |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 13 years |
| Lisa McLaughlin | F | - |
University of Michigan
| 14 years |
| Kuan Hsu | M | - |
University of Michigan
| 6 years |
| Walter Joseph Liu | M | 45 |
University of Michigan
| 5 years |
| Gísli S. Óttarsson | M | - |
University of Michigan
| 6 years |
| Kok Siong Yun | M | 54 |
University of Michigan
| 5 years |
| Robert Fogler | M | - |
University of Michigan
| 8 years |
| Ted Jenkins | M | - | 4 years | |
| Mike Flanagan | M | - |
University of Michigan
| 10 years |
| Andreas Utomo | M | 55 |
University of Michigan
| 5 years |
| Maicie Jones | F | - |
University of Michigan
| 12 years |
| Seksan Kiatsupaibul | M | 51 |
University of Michigan
| 5 years |
| Smith Jordan | M | - |
University of Michigan
| 7 years |
| Tonya Bakritzes | F | - |
University of Michigan
| 5 years |
| Robert G. Wilson | M | - |
University of Michigan
| 2 years |
| Elizabeth Maclin | F | - |
University of Michigan
| 2 years |
| Craig Millian | M | 56 | 4 years | |
| Douglass M. Rayburn | M | - |
University of Michigan
| 3 years |
| Avri Havron | M | 76 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 8 years |
| Edward Peter Hanson | M | 49 | 1 years | |
| Marian Gorecki | M | 83 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 9 years |
| Allen Bloom | M | 80 |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | - |
| John F. Heidenreich | M | - |
Augment Securities, Inc.
Augment Securities, Inc. Investment ManagersFinance Augment Securities, Inc. (Augment Securities) is a venture capital firm, a subsidiary of Spencer Trask & Co. founded in 1991 by Kevin Brian Kimberlin. The firm is headquartered in New York. | 14 years |
| Brian Stephen Matuszak | M | - |
University of Michigan
| 6 years |
| Adil Haque | M | - |
University of Michigan
| 4 years |
| Roman Perez-Soler | M | 70 |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | - |
| Bruce Cameron Greig | M | - |
University of Michigan
| 9 years |
| James Bunn | M | 51 |
University of Michigan
| 4 years |
| Annie Maxwell | F | - |
University of Michigan
| 5 years |
| Jay F. Whitacre | M | - |
University of Michigan
| 3 years |
| Fuad Fares | M | 68 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | - |
| Udi Eyal Fima | M | 60 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | - |
| Andrew Kaplan | M | 57 | 4 years | |
| Jason Park | M | 47 |
University of Michigan
| 5 years |
| Daniel Moon | M | - |
University of Michigan
| 10 years |
| Renu Gupta | M | 68 | - | |
| Farrokh Ayazi | M | - |
University of Michigan
| 4 years |
| Marc L. Walinsky | M | - |
University of Michigan
| 5 years |
| Martha P. Olson | F | 68 | 3 years | |
| Craig Zehnder | M | - |
University of Michigan
| - |
| Daniel Beltzman | M | 49 |
University of Michigan
| 5 years |
| Deborah Mielewski | M | - |
University of Michigan
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 93 | 93.00% |
| Israel | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Hochman
- Personal Network
